WorldQuant Millennium Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

WorldQuant Millennium Advisors’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.4M	Sell	24,442 -10,680	-30%	-$585K	﹤0.01%	550
2026 Q1	$1.98M	Sell	35,122 -413,723	-92%	-$24.1M	0.01%	426
2025 Q4	$26.7M	Buy	448,845 +438,940	+4,431%	+$23.9M	0.1%	195
2025 Q3	$536K	Sell	9,905 -491,243	-98%	-$28.1M	﹤0.01%	448
2025 Q2	$27.5M	Buy	501,148 +263,014	+110%	+$15.5M	0.14%	174
2025 Q1	$16.8M	Sell	238,134 -39,984	-14%	-$2.69M	0.11%	197
2024 Q4	$18.3M	Buy	278,118 +214,546	+337%	+$14.4M	0.12%	191
2024 Q3	$4.47M	Buy	+63,572	New	+$5.31M	0.03%	290
2023 Q1	–	Sell	-22,872	Closed	-$2.37M	–	357
2022 Q4	$2.37M	Sell	22,872 -154,461	-87%	-$14.5M	0.05%	254
2022 Q3	$15M	Buy	177,333 +92,275	+108%	+$8.22M	0.37%	92
2022 Q2	$7.05M	Buy	85,058 +60,231	+243%	+$4.8M	0.2%	154
2022 Q1	$1.91M	Sell	24,827 -35,024	-59%	-$2.93M	0.05%	250
2021 Q4	$5.29M	Sell	59,851 -23,150	-28%	-$1.91M	0.11%	215
2021 Q3	$6.42M	Buy	+83,001	New	+$6.55M	0.14%	187
2020 Q4	–	Sell	-32,717	Closed	-$2.49M	–	348
2020 Q3	$2.49M	Sell	32,717 -58,915	-64%	-$5.96M	0.06%	271
2020 Q2	$11.3M	Sell	91,632 -11,803	-11%	-$1.17M	0.26%	132
2020 Q1	$8.74M	Buy	103,435 +2,759	+3%	+$238K	0.21%	142
2019 Q4	$8.51M	Sell	100,676 -19,771	-16%	-$1.49M	0.16%	174
2019 Q3	$8.12M	Sell	120,447 -11,658	-9%	-$898K	0.16%	181
2019 Q2	$11.3M	Buy	132,105 +19,398	+17%	+$1.66M	0.22%	142
2019 Q1	$10M	Sell	112,707 -34,064	-23%	-$3.16M	0.24%	135
2018 Q4	$12.5M	Sell	146,771 -32,523	-18%	-$3.09M	0.37%	103
2018 Q3	$17.4M	Buy	179,294 +39,532	+28%	+$3.95M	0.58%	60
2018 Q2	$13.2M	Buy	+139,762	New	+$12.2M	0.51%	71

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

WorldQuant Millennium Advisors's BMRN Position: Q2 2026 in Review

WorldQuant Millennium Advisors reduced its BioMarin Pharmaceuticals (BMRN) stake by 30% in Q2 2026, selling an estimated $585K and leaving 24,442 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #550.

WorldQuant Millennium Advisors first reported a position in BMRN in Q2 2018 and has held it in 24 quarters since. The position peaked at $27.5M in Q2 2025. 562 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

WorldQuant Millennium Advisors held 24,442 shares of BioMarin Pharmaceuticals worth $1.4M as of Q2 2026.
WorldQuant Millennium Advisors sold 10,680 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $585K.
BioMarin Pharmaceuticals made up ﹤0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #550 holding.
WorldQuant Millennium Advisors first reported a position in BioMarin Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
WorldQuant Millennium Advisors's BioMarin Pharmaceuticals position peaked at $27.5M in Q2 2025.
562 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.